Effect of defensin on platelet functional activity
- 1 January 1993
- journal article
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 115 (1) , 23-25
- https://doi.org/10.1007/bf00846346
Abstract
The effects of human neutrophil peptide defensin were studied on human platelet function. Defensin (0.1-40 micrograms/mL) did not promote platelet aggregation. Defensin decreased platelet aggregation responses to ADF, collagen or thrombin. Defensin significantly lessened ATP level, released during platelet aggregation, and malondialdehyde production, induced by thrombin and collagen. These data reveal that defensins involve in cell-cell interaction between platelets and neutrophils counteracting agonist-induced platelet activation.Keywords
This publication has 10 references indexed in Scilit:
- Defensins: Endogenous antibiotic peptides of animal cellsCell, 1991
- DefensinsEuropean Journal of Haematology, 1990
- Monocyte-chemotactic activity of defensins from human neutrophils.Journal of Clinical Investigation, 1989
- Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factor.Proceedings of the National Academy of Sciences, 1989
- Inhibition of protein kinase C by defensins, antibiotic peptides from human neutrophilsBiochemical Pharmacology, 1988
- Isolation and structure of corticostatin peptides from rabbit fetal and adult lung.Proceedings of the National Academy of Sciences, 1988
- Human neutrophil elastase modulates platelet function by limited proteolysis of membrane glycoproteins.Journal of Clinical Investigation, 1985
- A possible role of protein kinase C in signal-induced lysosomal enzyme releaseBiochemical and Biophysical Research Communications, 1983
- Subcellular localization and properties of adenosine diphosphatase activity in human polymorphonuclear leukocytesBiochimica et Biophysica Acta (BBA) - General Subjects, 1981
- Preparation of Suspensions of Washed Platelets from HumansBritish Journal of Haematology, 1972